Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cannara Biotech Inc (OP:LOVFF)

1.290 UNCHANGED
Streaming Delayed Price Updated: 1:55 PM EDT, Sep 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.290
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 1.290
Today's Range 1.290 - 1.290
52wk Range 0.3971 - 1.420
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cannara Announces Grant of Options and RSUs
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire

Performance

YTD
+139.0%
+139.0%
1 Month
-6.7%
-6.7%
3 Month
+47.3%
+47.3%
6 Month
+46.3%
+46.3%
1 Year
+166.4%
+166.4%

More News

Read More
Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
This Week In Cannabis: Maryland Opens Lounges, DEA Wavers, Retail Trends Shift And More
Via Benzinga
Topics Cannabis
Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Cannara Secures 5 Key Listings in Québec’s New Vape Cartridge Category Including to be Released Live Rosin Vapes
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Cannara Biotech to Present at The Ventum Canadian Cannabis Conference on March 12th, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Cannara Biotech to Host Investor Webcast on June 25th, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
Via Benzinga
Topics Cannabis
Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow
Via Benzinga
Topics Cannabis
Canadian Cannabis Producer Cannara Reports 43% YoY Revenue Growth, Boosts Market Share And Profitability
Via Benzinga
Topics Cannabis
Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Cannara Announces Extension of BMO Credit Facility and Convertible Debenture to Enhance Financial Flexibility and Support Execution of its Long-Term Strategy
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground
Via Benzinga
Topics Cannabis
Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure
Via Benzinga
Topics Cannabis
Cannara Biotech Reports Q3 2024 Financial Results
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going
Via Benzinga
Topics Cannabis

Frequently Asked Questions

Is Cannara Biotech Inc publicly traded?
Yes, Cannara Biotech Inc is publicly traded.
What exchange does Cannara Biotech Inc trade on?
Cannara Biotech Inc trades on the OTC Traded
What is the ticker symbol for Cannara Biotech Inc?
The ticker symbol for Cannara Biotech Inc is LOVFF on the OTC Traded
What is the current price of Cannara Biotech Inc?
The current price of Cannara Biotech Inc is 1.290
When was Cannara Biotech Inc last traded?
The last trade of Cannara Biotech Inc was at 09/04/25 01:55 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback